focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks recover into end of week as airlines rise

Fri, 09th Jul 2021 08:42

(Alliance News) - London stocks were heading for a smoother end to a rocky week, with M&A activity and rising travel stocks helping to lift the mood in early dealings on Friday.

The FTSE 100 index was up 25.67 points, or 0.4%, at 7,056.33 early Friday. The mid-cap FTSE 250 index was up 100.13 points, or 0.4%, at 22,752.85. The AIM All-Share index was 0.1% higher at 1,249.30.

The Cboe UK 100 index was up 0.4% at 702.30. The Cboe 250 was 0.4% higher at 20,461.88, and the Cboe Small Companies up 0.1% at 15,414.13.

In mainland Europe, the CAC 40 in Paris was up 0.9% while the DAX 30 in Frankfurt gained 0.6% early Friday.

European markets were rebounding after sell-offs on Thursday, which saw the FTSE 100 plummet 1.7%.

"With increasing concern that the Delta variant (or indeed other variants) of the coronavirus will delay the forecast strengthening of economies over the second half of this year – a concern flagged yesterday by the San Francisco Fed's Mary Daly – risk aversion dominated yesterday's trading," said Daiwa Capital Markets.

The mood was largely downbeat in Asia on Friday. The Japanese Nikkei 225 index closed down 0.6%. In China, the Shanghai Composite closed flat, while the Hang Seng index in Hong Kong was up 0.9%, after diving 2.9% on Thursday. The S&P/ASX 200 in Sydney ended down 0.9%.

However, London stocks opened on the front foot, lifted by airline stocks.

Travel firms rose as people rushed to book summer getaways following the government's announcement that UK holidaymakers who have received two jabs from the NHS will no longer be required to self-isolate for 10 days on their return to England from destinations on the amber list.

Tourist hotspots such as Greece, France and Italy are currently on the UK government's amber list.

Travel firm Skyscanner said 30 minutes after the announcement, the agency saw a 53% increase in traffic from the UK compared to the same time on Wednesday. Thomas Cook said web traffic doubled in the moments after the announcement, and has only grown since.

British Airways parent International Consolidated Airlines rose 2.0% and mid-cap easyJet advanced 2.7%.

Bunzl was up 3.0%, sat atop the FTSE 100, after Berenberg raised the distribution and services stock to Buy from Hold.

Luxury fashion retailer Burberry rose 2.4% as it also got a boost from a ratings upgrade, with Goldman Sachs raising the trenchcoat maker to Buy from Neutral.

Vectura topped the FTSE 250, up 12% at 152.40 pence after agreeing to be taken over Marlboro cigarette maker Philip Morris International.

Philip Morris will pay 150p per share in cash for Vectura, a Wiltshire, England-based inhaled drug delivery devices maker. Including a 19p interim dividend, the deal values the FTSE 250 constituent at GBP1.04 billion.

Following the PMI offer, Vectura's directors withdrew their recommendation for a GBP958 million takeover by funds managed by private equity firm Carlyle Group. PMI's offer is a 10% premium to Carlyle's 136p per share bid.

However, with Vectura trading above PMI's offer price early Friday, investors could be anticipating a bidding war.

"PMI is expanding into products beyond tobacco and nicotine, as part of a natural evolution into a broader healthcare and wellness company," the New York-based company said.

Victrex edged up 1.0% as it saw upside risk to current full-year expectations, but warned of headwinds for the 2022 financial year.

The polymer supplier said it is seeing continued momentum in most end markets and posted 37% growth in third quarter revenue to GBP80.7 million, with sales volumes of 1,202 tonnes up 49% year-on-year.

On a year-to-date basis, being the nine months to June 30, revenue was up 10% year-on-year at GBP231.6 million.

"Reflecting the volume strength on a year to date basis, we now see the potential for some upside to current full year expectations, with our internal assumptions being closer to the upper end of market expectations," said Chief Executive Jakob Sigurdsson.

However, he noted that for the 2022 financial year, Victrex will have to contend with foreign currency headwinds, increasing raw material inflation, an anticipated uplift in innovation spend to support the long-term growth pipeline, and some costs associated with commissioning its China manufacturing facility.

"These effects will weigh on our 2022 prospects, although we remain focused on growth," said Sigurdsson.

In currency markets, the pound was clawing back some gains after a weaker-than-expected UK gross domestic product reading.

UK GDP grew 0.8% in May from April, missing forecasts for a stronger monthly gain of 1.7%, according to FXStreet, and below April's growth of 2.0%, which itself was revised down from 2.3%. The economy remains 3.1% below its pre-virus levels, the ONS said.

Sterling was trading at USD1.3773, up from USD1.3763 at the London equities close on Thursday.

The euro traded at USD1.1835 early Friday, down from USD1.1842 late Thursday. Against the yen, the dollar rose to JPY110.06 versus JPY109.79.

Gold was quoted at USD1,804.17 an ounce early Friday, higher than USD1,796.50 on Thursday. Brent oil was trading at USD74.50 a barrel, up from USD73.70 late Thursday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
4 Dec 2020 13:05

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

Read more
30 Nov 2020 09:53

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Read more
30 Nov 2020 08:06

Vectura signs asthma treatment deal with Kinaset

(Sharecast News) - Vectura has signed a global licence and development deal with Kinaset Therapeutics of the US for the development and commercialisation of the VR588 pan-JAK asthma treatment.

Read more
20 Nov 2020 08:34

Court denies GSK appeal in Vectura intellectual property dispute

(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.

Read more
19 Nov 2020 20:25

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

Read more
28 Sep 2020 15:53

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

Read more
22 Sep 2020 19:34

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

Read more
15 Sep 2020 17:22

Vectura Revenue Slips But Swings To First Half Profit

Vectura Revenue Slips But Swings To First Half Profit

Read more
14 Sep 2020 17:21

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

Read more
2 Sep 2020 19:36

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

Read more
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
9 Jun 2020 12:04

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

Read more
8 Jun 2020 15:00

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.